Cheng et al., sheds light on the extensive ramifications of the receptor activator of the nuclear factor-κB ligand (RANKL/RANK) system beyond its conventional skeletal functions, encompassing its involvement in immune modulation and the advancement of cancer. Here, TNFSF11 is linked to cancer.